BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

United States, BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

The best Articles in our Network

Sweden

Candela from Sweden raises €13.3M to scale Electric Hydrofoil Ferries and expand in the US

Founder Stories, Austria, Interviews

Interview with Markus Waghubinger | Co-Founder & CEO HalloSophia

Canada

Noble from Toronto secures $15M USD Series A to expand Digital Asset Issuance Platform

Netherlands

LearnWise secures €2M to revolutionize Student Support with AI

France

Eden AI from France secures €3M to simplify AI Integration for Businesses

United Kingdom

Lighthouse from London secures €351.8M and achieves Unicorn Status to expand AI Tools for Hospitality Sector

Previous

Next